FDA Approves Zoetis’ Convenia RTU for Dogs

FDA approval for Convenia RTU

Zoetis has received FDA approval for Convenia RTU for Dogs, according to Simplywall. The newly approved product is a single-dose injectable antibiotic for susceptible canine skin infections.

Simplywall reports that Convenia RTU provides up to 14 days of treatment. The formulation builds on Zoetis’ existing Convenia franchise and is intended for veterinarians treating dogs of all sizes.

Ready-to-use formulation

Simplywall describes Convenia RTU as a new formulation within the established Convenia franchise. The approval concerns use in dogs and focuses on susceptible canine skin infections.

The publisher says the formulation may be particularly relevant for medium to large breeds. Smaller-volume injections can be easier to administer in those dogs, according to Simplywall.

Points for veterinary sales conversations

For veterinary and animal-health sales professionals, the FDA decision creates an opportunity to focus discussions on the approved product profile reported by Simplywall: a single-dose injectable antibiotic, use for susceptible canine skin infections, and treatment coverage of up to 14 days.

The report also highlights administration considerations across dog sizes. In conversations with veterinary teams, the RTU formulation’s smaller injection volume may be relevant when discussing treatment of medium to large dogs.

Simplywall characterizes the approval as an addition to Zoetis’ existing Convenia franchise. The event centers on an FDA-approved formulation designed for veterinary use in dogs, rather than a new treatment category.

Key details reported by Simplywall

• FDA approval applies to Convenia RTU for Dogs.
• The product is a single-dose injectable antibiotic.
• It is intended for susceptible canine skin infections.
• Simplywall reports up to 14 days of treatment coverage.
• The formulation is aimed at veterinarians treating dogs of all sizes.
• Smaller-volume injections may be easier to administer for medium to large breeds.